Most people arrive here typing some version of best liver support for a steroid cycle.
No liver support supplement has ever been tested in people during anabolic steroid use. Not milk thistle, not NAC, not TUDCA, not ours. What changes your risk sits somewhere else entirely: which compound you take, at what dose, for how long, whether anyone reads your bloodwork, and whether you actually know what you are taking.
Injectables hit the liver too — not with jaundice, but with fat. Lean men who train still get it, at six times the odds of men who train without them.
What actually damages the liver
Oral anabolic steroids get modified at the 17-alpha position so they survive the first pass through the liver. That modification makes them work by mouth. It also makes them hard for the liver to break down.
The resulting injury runs predominantly cholestatic — bile stops flowing properly, most likely through suppression of bile-salt transporters such as ABCB11. Oxidative stress adds to it. Injectable compounds that skip the 17-alpha modification rarely, if ever, cause this cholestasis. They carry a different problem — fat.
What it looks like when it goes wrong
The US Drug-Induced Liver Injury Network followed 44 young men, mean age 33, who developed liver injury from anabolic steroids hidden in bodybuilding supplements. The picture repeated itself almost identically across all of them.
- Median time from starting to injury: 73 days. Not the first week — around week ten.
- 100% developed jaundice. Every single one.
- 84% had itching — the classic sign of blocked bile flow.
- 71% ended up in hospital.
Ten weeks matters. Plenty of people finish a short cycle feeling fine and conclude they got away with it. In this series that is when the injury typically arrived.
The half that should reassure you
In those 44 men, nobody died and nobody needed a liver transplant. The cholestasis resolved — slowly, over months, but it resolved. Liver biopsies, taken in 59% of the men, mostly showed profound cholestasis and mild hepatitis without bile duct destruction and without fibrosis.
A separate series of 25 cases from the Spanish and Latin-American registries reached the same endpoint: no deaths.
So the honest framing runs: this injury behaves badly and then usually recovers, provided you stop and get medical care. It rarely behaves like a one-way door.
The half that should not
The same Spanish registry recorded something worth sitting with. Anabolic steroid liver injury climbed from under 1% of all reported drug-induced liver injury in 2001–2009 to 8% in 2010–2013. Mean age of the men: 32.
Two further findings from that series:
- Bilirubin ran significantly higher than in liver injury from any other drug class (p = 0.001). This injury turns people yellow harder than almost anything else on the registry.
- In the cholestatic cases with pronounced jaundice, acute kidney injury developed. A liver problem became a kidney problem.
No deaths, then — but hospitalisation, months of jaundice and itching, and in some cases a second failing organ. “Survivable” and “fine” describe different things.
The four types of damage, and what actually changes each one
| Damage | Mechanism | What changes it |
|---|---|---|
| Cholestasis | Bile-salt transport suppressed; bile stops flowing | Stopping the compound. Nothing else is proven on cycle. |
| Hepatocellular injury | Liver cells damaged; ALT and AST rise | Dose and duration. Bloodwork catches it early. |
| Peliosis hepatis | Blood-filled cysts form in the liver | Avoiding long-term oral use. No supplement prevents it. |
| Adenoma / carcinoma | Long-term exposure drives abnormal liver cell growth | Duration above all. No supplement prevents it. |
Notice the third column. Not one row says “take X”.
Injectables are not safe for the liver — they damage it differently
Everything above concerns the orals. Here comes the part almost nobody in the gym knows.
The common belief runs: inject only, and the liver stays out of it. For cholestasis that holds. For fat it does not.
A Brazilian case-control study compared 180 recreational bodybuilders: 95 with a history of intramuscular anabolic steroid use against 85 non-users. All had an abdominal ultrasound and blood work.
- 12.6% of the users met the criteria for toxicant-associated fatty liver disease. Against 2.4% of controls.
- The odds ran six times higher (OR 6.0, 95% CI 1.3–27.6).
- Every case was asymptomatic. Nobody felt a thing.
One line in that paper deserves a pause. The authors note that these men carried low body fat and showed NO insulin resistance.
So this differs from the ordinary fatty liver that arrives with excess weight and sugar. Lean, training men with clean glucose still accumulated fat in the liver.
If your reasoning runs “I am lean and I train, so this does not apply to me” — that study was carried out on people exactly like you.
The same group later examined 182 bodybuilders who used anabolic steroids, median age 26, all asymptomatic. 38.5% had elevated liver enzymes, though CK was raised in most of them too, so part of that came from muscle. 12.1% showed hepatic steatosis on ultrasound.
Why steroids leave fat behind in the liver
The liver does not burn fat on site. It packages fat and ships it out to the rest of the body. When more arrives than leaves, the surplus stays inside the cells.
Anabolic steroids press on that system from several directions at once: they shift blood lipids, they alter how the liver handles fat, and a bulking calorie surplus sits on top of both.
For the packaging the liver needs choline: it builds the phosphatidylcholine that coats every fat particle on its way out, and methionine feeds a second route to the same molecule. Inositol and taurine have been studied for liver fat, so far mainly in animals. Zinc participates in antioxidant defence.
TUDCA and milk thistle do not address fat. TUDCA acts on bile flow, milk thistle on oxidative stress. Neither supplies the material the liver uses to move fat out.
Which makes “what is the best liver support” the wrong question. The right one: which of the two problems am I dealing with — the bile, or the fat.
What liver support can and cannot do
Three compounds dominate the conversation. Their popularity ranking and their evidence ranking run almost exactly backwards.
- Milk thistle — the most used, the weakest case here. Antioxidant action, nothing for bile flow. A Cochrane review in alcohol-related and viral liver disease found no clear evidence for or against benefit.
- NAC — the strongest human evidence of the three, for a completely different injury. It saves lives in paracetamol overdose, where the problem is glutathione depletion. That evidence does not transfer to cholestasis.
- TUDCA — the best mechanistic fit, because cholestasis is a bile-flow problem and TUDCA acts on bile flow. Human data comes from cholestatic liver disease, not from steroid users.
The full comparison sits in a separate article on TUDCA, NAC and milk thistle, including why the forum consensus formed the way it did.
None of them prevents peliosis hepatis or adenoma, and none removes the dose- and duration-dependent risk of 17-alpha-alkylation. Treating any supplement as permission to run more, or longer, inverts the entire point.
What actually changes your risk
In rough order of how much each one moves the needle:
- Not using 17-alpha-alkylated orals. Everything else on this list competes for second place.
- Duration. The severe outcomes cluster around prolonged use. The median injury in the DILIN series landed at day 73.
- Dose. The risk tracks the dose, and “just a bit more” compounds with time.
- Bloodwork, ordered and read by a clinician — before and during. You will not feel cholestasis coming. Jaundice and itching arrive late.
- Knowing what sits in the product. Batch testing and a full label, or you do not know what you are taking.
- Telling your doctor the truth. A young man with jaundice and no disclosed steroid use gets investigated for the wrong things first, and loses time.
Not one item on that list arrives in a tub. Which is why this page reads differently from the rest of the results you opened.
Where a supplement honestly fits
After all of the above, a fair question remains: does anything in a tub help at all?
It depends which of the two problems you face. For the cholestasis from orals, nothing in a tub carries evidence that it helps. For the fat the picture differs, because there the question concerns raw material rather than medicine.
LiverGuard exists for that second half — the fat, not the bile. If you want to see exactly what goes into it, its page carries the full label: choline, inositol, methionine, taurine and zinc, each with its dose, from a product with a batch number. Choline contributes to normal lipid metabolism and to the maintenance of normal liver function. That wording comes from the European regulator, and we will not stretch past it. That covers the whole claim.
It carries no trial during steroid use — nothing does. It does not prevent peliosis hepatis, adenoma or carcinoma. It does not make an oral cycle safe, and it does not replace bloodwork.
What it does offer over the alternative: you know exactly what you swallowed.
This article provides information, not medical advice. It does not endorse anabolic steroid use and it is not a protocol.
Frequently asked questions
What is the best liver support for a steroid cycle?
On mechanism alone, TUDCA, because the injury is cholestatic and TUDCA acts on bile flow. On evidence, none of them: no liver support supplement has been tested in people during anabolic steroid use. Anyone naming a winner is guessing confidently.
Does milk thistle protect the liver on cycle?
Not demonstrably. It has a good safety record and a plausible antioxidant mechanism, but it does nothing for bile transport, which is the actual injury here. Hepatoprotection against anabolic steroids has been reported in rats, not in people.
How long before liver damage shows up?
In the DILIN series of 44 men the median was 73 days. That is around week ten, well after most people conclude their cycle went fine. Cholestatic injury also gives no warning you can feel until jaundice or itching appear.
Is anavar safer for the liver than dianabol?
Both carry the 17-alpha-alkyl modification, which is the feature that drives the liver injury. Oxandrolone is often described as milder, but the mechanism is identical and the risk still tracks dose and duration. Milder is not the same as safe.
Will my liver recover?
In both published series the answer was yes: nobody died, and in the DILIN series nobody needed a transplant and biopsies showed no fibrosis. But recovery ran slow — months of jaundice — 71% were hospitalised, and some cholestatic cases developed acute kidney injury. Recovery depends on stopping and getting care.
Do injectable steroids affect the liver?
Not with cholestasis — that belongs to the 17-alpha-alkylated orals. But in a Brazilian case-control study of 180 bodybuilders, men using intramuscular anabolic steroids met the criteria for toxicant-associated fatty liver disease at 12.6% against 2.4% of non-users, six times the odds. Those men were lean and showed no insulin resistance, and every case was symptom-free. Bloodwork before and during, read by a clinician, remains the only way to see it.
References
- Schwingel, P. A., Cotrim, H. P., Salles, B. R., et al. (2011). Anabolic-androgenic steroids: a possible new risk factor of toxicant-associated fatty liver disease. Liver International, 31(3), 348-353. PMID: 21040407
- Schwingel, P. A., Cotrim, H. P., Santos, C. R., et al. (2015). Recreational anabolic-androgenic steroid use associated with liver injuries among Brazilian young men. Substance Use & Misuse, 50(11), 1490-1498. PMID: 26549387
- Stolz, A., Navarro, V., Hayashi, P. H., et al. (2019). Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors. Alimentary Pharmacology & Therapeutics, 49(9), 1195-1204. PMID: 30934130
- Robles-Diaz, M., Gonzalez-Jimenez, A., Medina-Caliz, I., et al. (2015). Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids. Alimentary Pharmacology & Therapeutics, 41(1), 116-125. PMID: 25394890
- Navarro, V. J., Barnhart, H., Bonkovsky, H. L., et al. (2014). Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology, 60(4), 1399-1408. PMID: 25043597
- Bond, P., Llewellyn, W., & Van Mol, P. (2016). Anabolic androgenic steroid-induced hepatotoxicity. Medical Hypotheses, 93, 150-153. DOI: 10.1016/j.mehy.2016.06.004
- Solimini, R., Rotolo, M. C., Mastrobattista, L., et al. (2017). Hepatotoxicity associated with illicit use of anabolic androgenic steroids in doping. European Review for Medical and Pharmacological Sciences, 21(1 Suppl), 7-16. PMID: 28379599
- Rambaldi, A., Jacobs, B. P., & Gluud, C. (2007). Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases. Cochrane Database of Systematic Reviews, (4), CD003620. PMID: 17943794
- Kelly, G. S. (1998). Clinical applications of N-acetylcysteine. Alternative Medicine Review, 3(2), 114-127. PMID: 9577247
- Larghi, A., Crosignani, A., Battezzati, P. M., et al. (1997). Ursodeoxycholic and tauro-ursodeoxycholic acids for the treatment of primary biliary cirrhosis: a pilot crossover study. Alimentary Pharmacology & Therapeutics, 11(2), 409-414. PMID: 9146783
- Hartgens, F., & Kuipers, H. (2004). Effects of androgenic-anabolic steroids in athletes. Sports Medicine, 34(8), 513-554. DOI: 10.2165/00007256-200434080-00003
- Petrovic, A., Vukadin, S., Sikora, R., et al. (2022). Anabolic androgenic steroid-induced liver injury: an update. World Journal of Gastroenterology, 28(26), 3071-3080. DOI: 10.3748/wjg.v28.i26.3071
- Radovanović, D., Jovanović, D., Mihailović, D., et al. (2003). Hepatoprotective effects of silymarin in androgenic-anabolic steroid-induced liver damage. Medicinski Pregled, 56(Suppl 1), 79-83. PMID: 15510919
- Pani, A., Giossi, R., Menichelli, D., et al. (2020). Inositol and non-alcoholic fatty liver disease: a systematic review on deficiencies and supplementation. Nutrients, 12(11), 3379. DOI: 10.3390/nu12113379
Go deeper on each compound
- TUDCA vs NAC vs milk thistle
- Does milk thistle protect your liver on cycle?
- TUDCA on cycle: what the evidence shows
- ALT and AST: muscle or liver?
- High GGT, TUDCA and UDCA
